- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Kwality Pharmaceuticals Ltd — Board Meeting, 13-11-2025: Board Meeting
13-11-2025 | 01:40 pm
13-11-2025 | 01:40 pm
Kwality Pharma's board approved H1 FY26 results. Revenue surged 32% YoY to ₹224 Cr, EBITDA rose 35% to ₹50 Cr, and Net Profit hit ₹26 Cr. Q3 revenue is expected around ₹140 Cr, with the company confident of exceeding ₹500 Cr for full FY26.
No comments yet. Be the first to comment!